文献速递腹部介入CTMR

LI-RADS TRA V2024:肝细胞癌局部区域治疗后影像学评估的创新

LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies.
PubMed 文献 · Abdom Radiol (NY) · 2025-08-27

本文综述LI-RADS治疗反应评估(TRA)算法在肝细胞癌局部区域治疗后的应用进展,重点介绍2024版更新对放射性治疗(如经动脉放射性栓塞和立体定向体部放疗)后影像特征与热消融及经动脉化疗栓塞后差异的改进,并指出需前瞻性验证新算法以确认其诊断性能和临床影响。

要点

  • 2024版LI-RADS TRA更新针对放射性治疗后影像特征进行细化,以提高诊断准确性。
  • 不同局部区域治疗(热消融、经动脉化疗栓塞、放射性治疗)后影像表现存在差异,需区分判读。
  • 新算法尚需前瞻性验证以确认其诊断性能和临床影响。

核心结论

  • 2024版LI-RADS TRA更新引入改进以优化局部区域治疗后肝细胞癌治疗反应评估的诊断准确性;新算法需前瞻性验证以确认其诊断性能和临床影响。

研究设计与样本

  • 综述,检索范围与纳入文献数原文未报告。

关键影像表现/征象

  • 放射性治疗(经动脉放射性栓塞和立体定向体部放疗)后影像特征常不同于热消融和经动脉化疗栓塞后表现。

局限性

  • 需前瞻性验证新算法以确认其诊断性能和临床影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The Liver Imaging Reporting and Data System (LI-RADS) has become an essential tool for standardizing the detection, diagnosis, and treatment response assessment of hepatocellular carcinoma (HCC) using contrast-enhanced CT and MRI. With the rising incidence of HCC, the use of local-regional therapies (LRT) has also expanded. To address the increasing complexity of post-treatment imaging interpretation, the LI-RADS Treatment Response Assessment (TRA) algorithm was developed to provide a structured and reproducible approach for evaluating tumor response following various forms of LRT. However, imaging features following radiation-based therapies-such as transarterial radioembolization and stereotactic body radiation therapy-often differ from those seen after thermal ablation and transarterial chemoembolization. Recognizing these differences, the 2024 LI-RADS TRA update introduces refinements to improve diagnostic accuracy in this context. This review outlines the evolving role of LI-RADS in post-treatment assessment, highlights imaging findings associated with different LRTs, and explores ongoing refinements aimed at optimizing its clinical utility. Finally, we discuss the need for prospective validation of the new algorithm to confirm its diagnostic performance and clinical impact.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wakate Teruya AK, Miranda J, Leão Filho H, et al. LI-RADS TRA V2024: innovations in imaging assessment of hepatocellular carcinoma response to locoregional therapies. Abdom Radiol (NY). 2025. PMID: 40864274. doi:10.1007/s00261-025-05110-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。